Biotech | October 11, 2022
Panacea Biotec bags US $127.30 mn for supply of Pentavalent Vaccine
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
This acquisition will accelerate Medcare's plans to emerge as an international hub for health, beauty, and wellness adding to its existing network of 4 hospitals and over 20 medical centres in the UAE.
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
The country has been witnessing a progressive reduction in IMR, U5MR and NMR
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
Phase 2 study evaluating an investigational weekly oral combination treatment regimen of islatravir and Gilead Sciences’ lenacapavir to resume with lower dose of islatravir
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
The #pledgemyeyes initiative reached out to over 30 million people across the country and the website registered 3X more pledges compared to the present numbers
Subscribe To Our Newsletter & Stay Updated
